Wells Fargo Maintains Overweight on Boston Scientific, Raises Price Target to $62
Portfolio Pulse from Benzinga Newsdesk
Wells Fargo analyst Larry Biegelsen has maintained an Overweight rating on Boston Scientific (NYSE:BSX) and increased the price target from $59 to $62.
December 13, 2023 | 3:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Wells Fargo analyst Larry Biegelsen maintains an Overweight rating on Boston Scientific and raises the price target from $59 to $62, indicating a positive outlook on the stock.
The increase in price target by a reputable analyst typically signals a bullish outlook on the stock, suggesting that the analyst expects the stock to perform well in the near term. Investors often view such updates as a positive sign, which can lead to an increase in stock price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100